The Coagulopathy of Chronic Liver Disease | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

These recommendations provide a data-supported approach to the management of patients
with varices and variceal hemorrhage. They are based on the following:(1) formal review …

The prevention and management of bleeding and thrombosis in patients with cirrhosis
poses several difficult clinical questions. These Clinical Practice Guidelines have been …

This guidance provides a data-supported approach to risk stratification, diagnosis, and
management of patients with cirrhosis and portal hypertension (PH). A guidance document …

1 ESGE recommends that patients with compensated advanced chronic liver disease
(ACLD; due to viruses, alcohol, and/or nonobese [BMI< 30 kg/m 2] nonalcoholic …

Background Patients with cirrhosis in Child–Pugh class C or those in class B who have
persistent bleeding at endoscopy are at high risk for treatment failure and a poor prognosis …

Background The use of recombinant activated factor VII (rFVIIa) on an off-label basis to treat
life-threatening bleeding has been associated with a perceived increased risk of …

Patients with acute and chronic liver disease frequently acquire unique changes in
haemodynamic and haemostatic pathways that may result in life-threatening bleeding and …

The role played by coagulation defects in the occurrence of bleeding in cirrhosis is still
unclear. This is partly due to the lack of tests that truly reflect the balance of procoagulant …

Prolonged prothrombin time and thrombocytopenia are common in patients with cirrhosis.
These parameters do not reflect the overall hemostatic rebalance or bleeding risk in the …